MTCM
RVNC

Mint Tower Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Mint Tower Capital Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-187,443
Closed -$570K – 168
2024
Q4 		$570K Buy
187,443
+127,443
+212% +$388K 0.14% 65
2024
Q3 		$311K Buy
+60,000
New +$311K 0.1% 64